Article Text
Statistics from Altmetric.com
Q In patients with chronic major depressive disorder (MDD), does the cognitive behavioural analysis system of psychotherapy [CBASP] prevent recurrence?
Clinical impact ratings Psychiatry ★★★★★★☆ GP/FP/Mental health ★★★★★☆☆
METHODS
Design:
randomised controlled trial.
Allocation:
{concealed*}†.
Blinding:
blinded ({data collectors}† and outcome assessors).*
Follow up period:
1 year maintenance phase (after 12 wks in a treatment phase and 16 wks in a continuation phase).
Setting:
12 academic centres in the US.
Patients:
82 patients who were 18–75 years of age (mean age 45 y, 67% women); began the treatment phase with a DSM-IV diagnosis of MDD (duration ⩾2 y) and a score ⩾20 on the 24 item Hamilton Rating Scale for Depression (HRSD-24); and responded to CBASP alone during the treatment …